Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,359.00
Bid: 2,358.00
Ask: 2,359.00
Change: 10.00 (0.43%)
Spread: 1.00 (0.042%)
Open: 2,358.00
High: 2,367.00
Low: 2,351.00
Prev. Close: 2,349.00
BATS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BAT To Appoint New Chairman

15 Oct 2020 07:00

RNS Number : 1277C
British American Tobacco PLC
15 October 2020
 

British American Tobacco p.l.c.

15 October 2020

 

BAT To Appoint New Chairman

 

We are pleased to announce that Luc Jobin will succeed Richard Burrows as Chairman of British American Tobacco p.l.c. (BAT). This will take effect from the conclusion of the Company's Annual General Meeting (AGM) on 28 April 2021 and, in order to ensure an effective transition of the leadership of the Board, Mr Jobin will be appointed as Chairman Designate of BAT effective 1 March 2021.

 

As BAT accelerates the delivery of its transformation strategy towards A Better Tomorrow and following a comprehensive search of external and internal candidates the Board unanimously concluded that Mr Jobin's experience of enterprise transformation, extensive North American knowledge and cross-industry credentials make him the right candidate to lead the Board.

 

His passion for shaping sustainable businesses aligns strongly with the BAT culture and ethos. He is currently an independent Director on the Boards of Gildan Activewear Inc and Hydro-Québec.

 

Mr Jobin joined the BAT Board in 2017 as an independent Non-Executive Director. During his executive career, he was President and Chief Executive Officer of Canadian National Railway Company, prior to which he was Executive Vice President and Chief Financial Officer. Previously, Mr Jobin was Executive Vice President of Power Corporation of Canada (an international financial services company), and held the roles of Chief Financial Officer and, between 2003 and 2005, Chief Executive Officer of Imperial Tobacco Canada. 

 

Mr Burrows will step down as Chairman and retire from the Board at the end of the Company's 2021 AGM.

 

Commenting on Mr Jobin's appointment, Dimitri Panayotopoulos, Senior Independent Director said:

 

"The Board was clear that it was looking for a candidate with energy and personality to lead the Board while BAT embraces the strategic opportunities of our corporate transformation. His significant North American experience and his track record in consumer and customer businesses, set against a strong list of external and internal candidates, made Luc the ideal candidate."

 

Current Chairman, Richard Burrows said:

 

"I am delighted that the Board has appointed Luc as the incoming Chairman for BAT. Luc brings with him significant financial, regulatory and M&A experience. He has been an outstanding non-executive director over the last three years, providing consistent support, insight and constructive challenge through the development of strategy. I am sure that BAT will go from strength to strength with Luc as Chairman and Jack Bowles as Chief Executive Officer."

 

As a current Non-Executive Director of BAT, the appointment of Mr Jobin will enable an effective transition to the role of Chairman in these restricted COVID times and allow BAT to maintain its clear focus on accelerating the transformation of its business.

 

Enquiries:

 

British American Tobacco Press Office

+44 (0) 20 7845 2888 (24 hours) | @BATPress

 

British American Tobacco Investor Relations

Mike Nightingale / Victoria Buxton / William Houston / John Harney

+44 (0) 20 7845 1180/2012/1138/1263

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABLBDGRUBDGGS
Date   Source Headline
13th Nov 20232:15 pmRNSDirector/PDMR Shareholding
8th Nov 20239:55 amRNSDirector/PDMR Shareholding
8th Nov 20239:50 amRNSDirector/PDMR Shareholding
8th Nov 20239:45 amRNSDirector/PDMR Shareholding
2nd Nov 20231:15 pmRNSDirector/PDMR Shareholding
2nd Nov 20237:00 amRNSBAT Appoints Chief Financial Officer
1st Nov 202312:10 pmRNSTotal Voting Rights
13th Oct 20237:00 amRNSBAT Appoints Chief People Officer
5th Oct 20231:00 pmRNSDirector/PDMR Shareholding
5th Oct 20237:00 amRNSDirectorate Change
2nd Oct 20231:40 pmRNSTotal Voting Rights
26th Sep 20232:40 pmRNSDirector/PDMR Shareholding
18th Sep 20237:00 amRNSBranch Register: Dividend Finalisation Information
14th Sep 20239:00 amRNSRussia business update - sale completed
12th Sep 20233:05 pmRNSDirector/PDMR Shareholding
7th Sep 20231:15 pmRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSRussia business update – agreement signed
1st Sep 202310:30 amRNSTotal Voting Rights
24th Aug 20233:40 pmRNSDirector/PDMR Shareholding
22nd Aug 20234:50 pmRNSDirector/PDMR Shareholding
22nd Aug 20233:50 pmRNSDirector/PDMR Shareholding
22nd Aug 202312:25 pmRNSDirector/PDMR Shareholding
22nd Aug 202312:20 pmRNSDirector/PDMR Shareholding
22nd Aug 202312:15 pmRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSCompany Secretary Change
14th Aug 20234:53 pmRNSTender Offer Pricing
14th Aug 202311:30 amRNSResult of Tender Offer
3rd Aug 20233:30 pmRNSDirector/PDMR Shareholding
3rd Aug 202310:20 amRNSPublication of Supplementary Prospectus
1st Aug 202311:38 amRNSPricing Notes Offering
1st Aug 202310:35 amRNSTotal Voting Rights
31st Jul 20231:26 pmRNSTender Offer
26th Jul 20237:00 amRNSHalf-year Report
6th Jul 20233:00 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSBranch Register: Dividend Finalisation Information
3rd Jul 20231:40 pmRNSBlock listing Interim Review
3rd Jul 20231:30 pmRNSTotal Voting Rights
20th Jun 202311:00 amRNSDirector/PDMR Shareholding
19th Jun 20237:00 amRNSManagement Board Changes
8th Jun 202312:45 pmRNSDirector/PDMR Shareholding
6th Jun 202310:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNS2023 First Half Pre-Close Trading Update
1st Jun 202311:00 amRNSTotal Voting Rights
31st May 202310:45 amRNSDirector/PDMR Shareholding
24th May 20234:35 pmRNSDirector/PDMR Shareholding
22nd May 20232:00 pmRNSHolding(s) in Company
15th May 20237:00 amRNSBAT announces Tadeu Marroco as Chief Executive
12th May 20234:45 pmRNSDirector/PDMR Shareholding
12th May 202312:10 pmRNSHolding(s) in Company
11th May 20233:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.